SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bräunig, P.
Right arrow Articles by Krüger, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bräunig, P.
Right arrow Articles by Krüger, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Levetiracetam in the Treatment of Rapid Cycling Bipolar Disorder

Peter Bräunig

Klinik für Psychiatrie; Verhaltensmedizin und Psychosomatik, Chemnitz, University of Dresden, Dresden, Germany.

Stephanie Krüger

Department of Psychiatry, University of Dresden, Dresden, Germany.

Levetiracetam (LEV) is a novel anticonvulsant that is currently investigated in bipolar disorder. It may be useful in the treatment of refractory and complicated cases, in which conventional mood stabilizers are not effective. We report two cases of rapid cycling bipolar disorder in which the add-on of LEV to a conventional treatment regimen improved symptoms of depression, as well as those of mania/mixed mania, and disrupted the severe rapid cycling pattern.

Key Words: depression • levetiracetam • mania • mixed mania • rapid cycling bipolar disorder

Journal of Psychopharmacology, Vol. 17, No. 2, 239-241 (2003)
DOI: 10.1177/0269881103017002015
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
F Ovsiew
Antiepileptic drugs in psychiatry
J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1655 - 1661.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
J. W. Wheless and B. F. D. Bourgeois
Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders
J Child Neurol, August 1, 2004; 19(1_suppl): S39 - S48.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
J. W. Wheless and B. F. D. Bourgeois
Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders
J Child Neurol, January 1, 2004; 19(1_suppl): S39 - S48.
[Abstract] [PDF]


Advertisement